Veterinary medicines containing enrofloxacin to be administered via the drinking water to chickens and/or turkeys

  • Procedure started
  • Under evaluation
  • CHMP opinion
  • European Commission final decision
Current status:
European Commission final decision

Overview

Questions and answers on use of enrofloxacin-containing veterinary medicines administered via drinking water to chickens and turkeys

Follow-up assessment after the referral under Article 35 of Directive 2001/82/EC (EMEA/V/A/089)

On 14 February 2018, the European Medicines Agency updated its recommendations for enrofloxacin-containing medicines administered via drinking water to chickens and turkeys. The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that these products should no longer be used in chickens and turkeys to treat Escherichia coli infections and that the product information for the products should be amended accordingly.

Key facts

Approved name
Veterinary medicines containing enrofloxacin to be administered via the drinking water to chickens and/or turkeys
International non-proprietary name (INN) or common name
enrofloxacin
Reference number
EMEA/V/A/089
Type
Article 35

Community interest referral: initiated in cases involving the interests of the Community or concerns relating to the protection of human or animal health or the environment.

Status
European Commission final decision
Opinion date
07/11/2013
EC decision date
28/02/2014

All documents

Document description

  • Opinion - contains the CVMP opinion of the referred medicine(s)
  • List of the medicines affected by the referral (Annex I)
  • Scientific conclusions of the Committee (Annex II)

The following two documents may not always be available:

News

How useful was this page?

Add your rating